The Latest 

The FDA has announced the recall of one brand of a popular type 2 diabetes drug, metformin, over a potentially cancer-causing impurity.

Fears about potentially deadly crystallization in herpes drug vials have spurred Zydus Cadila to yank four lots from the U.S. market.

Reliance on foreign manufacturers, particularly those in China and India, has proven to be a major factor in causing shortages.

Officials urged drug recalls in 2018 but have yet to recommend action on latest impurity findings.

With inspectors’ travel slowed, some nations are using head-mounted cameras and web conferencing to conduct foreign safety audits.

15 Indian companies received notices out of 32 warning letters issued by the U.S. FDA.

The company, a subsidiary of India-based Emcure Pharmaceuticals, is accused of working with other generic drug makers to fix prices.